~After EHDEN's 5th Data Partner Call: 143 Data Partners in 27 Countries!~

On a mission to become the trusted open science community built for health data research via a European federated network

Data Partners

Find out more about the EHDEN federated network

SME Catalogue

Browse our online catalogue of EHDEN-trained and certified SMEs

EHDEN Academy

Publicly available, free and on-demand training developed by the OHDSI and EHDEN community

Welcome to the European Health Data & Evidence Network (EHDEN), an IMI 2 consortium with 23 partners operating in Europe.

Welcome to the website of the European Health Data & Evidence Network (EHDEN), operating within the Innovative Medicines Initiative across the European region.

EHDEN was launched to address the current challenges in generating insights and evidence from real-world clinical data at scale, to support patients, clinicians, payers, regulators, governments, and the industry in understanding wellbeing, disease, treatments, outcomes and new therapeutics and devices.

With a new phase of the COVID-19 pandemic, the project wishes those recovering, those still affected, and those bereaved our best for the future. Clearly, we have all been affected by this pandemic, and equally, the project too, and sadly continue to be affected, but we will aim to mitigate this as best as practicable.

EHDEN is proud to have collaborated with OHDSI colleagues in ongoing studies since March 2020 on COVID-19, see more information here and on the OHDSI website here. Meanwhile, our thanks to all who we work with in reaching our collective mission.

Our podcast series, Voice of EHDEN, season 1 is available, listen to the trailer and 8 episodes here. Season 2 will commence soon....

Our 5th Data Partner call (13th October - 15th November) received 90 applications from 24 countries, and we selected 49 new and existing Data Partners, with a total now of 143 in 27 countries across the European region. The 2022 Data Partner calls will be announced at the end of January.

Continue to stay safe and well, and we look forward to collaborating in 2022.